BioSpring, Dr. Reddy's, InteRNA Technologies, Quiet Therapeutics, Laboratory of Pharmacology and Toxicology (LPT) GmbH & Co. KG, VU University Medical Center ca

The MIRacle Consortium received a €1.2 million ($1.6 million) grant from the EU's Framework Programme 7 (FP7) to develop tumor-selective microRNA-based therapeutics to treat head and neck cancer. The ...